AKAN
Akanda Corp
NASDAQ: AKAN · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$24.79
-4.64% today
Updated 2026-06-05
Market cap
$9.04M
P/E ratio
0.02
P/S ratio
10.80x
EPS (TTM)
$696.80
Dividend yield
—
52W range
$2 – $121
Volume
2.8M
WallStSmart proprietary scores
24
out of 100
Grade: F
Strong Sell
Investment rating
4.7
Growth
C3.5
Quality
D2.0
Profitability
F6.7
Valuation
B1/9
Piotroski F-Score
Weak
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$1.55
-93.75%
12-Month target
$1.55
-93.75%
Intrinsic (DCF)
—
Margin of safety
—
Price chart
Stock snapshot
Strengths
+ Revenue growth 21.90% QoQ
Risks
- Piotroski 1/9 — weak financial health
- Thin margins at -266.30%
- Negative free cash flow $-7.96M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $2.62M | $2.16M | $836664.00 | $258075.00 | $836660.00 |
| Net income | $-11.66M | $-32.28M | $-4.10M | $-45.65M | $-45.65M |
| EPS | — | — | — | — | $696.80 |
| Free cash flow | $-11.78M | $-1.50M | $-6.08M | $-7.96M | $-7.96M |
| Profit margin | -445.00% | -1,494.18% | -489.57% | -17,690.19% | -266.30% |
Peer comparison
Smart narrative
Akanda Corp trades at $24.79. representing a P/E of 0.02x trailing earnings. Our Smart Value Score of 24/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score. TTM revenue stands at $836660.00. with profit margins at -266.30%.
Frequently asked questions
What is Akanda Corp's stock price?
Akanda Corp (AKAN) trades at $24.79, on a P/E of 0.0x and a P/S of 10.8x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Akanda Corp overvalued?
Akanda Corp carries a Smart Value Score of 24/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.
What is the price target of Akanda Corp (AKAN)?
The 12-month analyst consensus target is $1.55, about 93.7% below the current $24.79. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is Akanda Corp's revenue?
Akanda Corp's trailing twelve-month revenue is $836660.00. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Company info
SectorHEALTHCARE
IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio10.80x
ROE-948.39%
Beta14.61
50D MA$15.04
200D MA$29.75
Shares out0.00B
Float0.00B
Short ratio—
Avg volume2.8M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—